Combination atypical antipsychotic (olanzapine) + SSRI (fluoxetine)

Symbyax (olanzapine/fluoxetine) Withdrawal

Symbyax is unusual because you are stopping two drugs at once. The fluoxetine half is among the gentlest antidepressants to come off - its very long half-life means it tapers itself and rarely produces brain zaps or an abrupt discontinuation syndrome. The olanzapine half is the one that needs attention: stopping an antipsychotic can produce cholinergic rebound (nausea, sweating, insomnia, agitation) and, in susceptible patients, rebound symptoms of the underlying illness. Because Symbyax is approved specifically for bipolar depression and treatment-resistant depression, relapse of the mood disorder is the larger concern for many patients.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

Two very different components: olanzapine ~30 hours, and fluoxetine ~1-4 days for the parent drug with an active metabolite (norfluoxetine) of 7-15 days. The long fluoxetine tail effectively self-tapers the SSRI side, while the olanzapine component clears faster and drives most of the discontinuation experience.

Withdrawal timeline

Onset— 1-4 days after stopping (olanzapine side)

Cholinergic-rebound symptoms from the olanzapine component - nausea, sweating, insomnia, restlessness - tend to appear within a few days. The fluoxetine side usually stays quiet thanks to its long half-life.

Peak— Days 3-10

Any rebound insomnia, agitation, or GI upset is generally most noticeable in the first week to ten days as olanzapine clears.

Resolution— 2-4 weeks; watch for mood relapse beyond that

Acute rebound symptoms usually settle within a few weeks. Separately, and often later, the underlying bipolar depression or treatment-resistant depression can re-emerge - a distinct process from discontinuation that warrants its own plan.

Common symptoms

  • Insomnia and restlessness
  • Nausea (cholinergic rebound)
  • Sweating
  • Anxiety or agitation
  • Return of depressive symptoms

Less common

  • Vivid dreams
  • Irritability
  • Dizziness

Notable / pattern-defining symptoms

Cholinergic rebound - because olanzapine blocks acetylcholine receptors, stopping it can unleash a temporary cholinergic surge (nausea, cramping, sweating, insomnia). Tapering the olanzapine component slowly limits this.

Mood relapse in bipolar illness - discontinuing a medication approved for bipolar depression can destabilize mood, including a swing toward mania or a return of depression. This is not a withdrawal effect but a relapse risk, and it is the main reason Symbyax changes are closely supervised.

Tapering guidance

  • The olanzapine component should be tapered gradually to limit cholinergic rebound and mood destabilization; the fluoxetine component largely self-tapers because of its long half-life but is still reduced under guidance.
  • Because the drug treats bipolar depression and treatment-resistant depression, a relapse-prevention plan (monitoring, and often a bridging or maintenance strategy) should be in place before stopping.
  • Watch for early signs of mood change - both depressive and manic - during and after the taper.
  • Always coordinate the taper with the prescribing physician; do not adjust the dose without supervision.

Where ketamine therapy fits

Symbyax patients are, by definition, being treated for bipolar depression or treatment-resistant depression - the same populations where ketamine is most studied. Ketamine does not treat Symbyax discontinuation, but when the underlying depression persists or returns, it is a different-mechanism option worth a coordinated discussion. One important caution: in bipolar illness, ketamine carries a theoretical risk of triggering a manic or hypomanic switch, so it must be used carefully and only in coordination with the prescribing psychiatrist.

Check ketamine therapy eligibilityMedication safety with ketamine

Frequently asked questions

What makes stopping Symbyax different from other antidepressants?

Symbyax is two drugs in one - the antipsychotic olanzapine and the SSRI fluoxetine. The fluoxetine side comes off gently because its long half-life self-tapers, but the olanzapine side can cause cholinergic rebound (nausea, sweating, insomnia, agitation) and needs its own gradual taper. Relapse of the underlying mood disorder is the larger concern.

How long do Symbyax withdrawal symptoms last?

Acute rebound symptoms from the olanzapine component usually appear within a few days, peak over days 3-10, and settle within 2-4 weeks. Separately, the underlying bipolar or treatment-resistant depression can return later - a relapse process rather than withdrawal - which is why follow-up matters.

Can I stop Symbyax on my own?

No. Because Symbyax treats bipolar depression and treatment-resistant depression, stopping it can destabilize mood - including a swing toward mania or a return of depression - and the olanzapine component can cause cholinergic rebound. Any change should be tapered under close psychiatric supervision with a relapse-prevention plan in place.

Is ketamine therapy an option for the depression Symbyax was treating?

Ketamine is among the most studied options for treatment-resistant depression and is used for bipolar depression with caution. It is a different mechanism from Symbyax. Importantly, in bipolar illness ketamine carries a theoretical risk of triggering a manic switch, so it is used only in close coordination with the prescribing psychiatrist - never as a self-directed substitution.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.